ELEDON PHARMACEUTICALS
5.0700
06-十一月-24 15:59:47
15 分钟延时
股票
+0.0800
+1.60%
今日范围
5.0100 - 5.3999
ISIN
N/A
来源
NASDAQ
-
06 11月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
29 10月 2024 07:46:00 条件 Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference
11 9月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
04 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results
14 8月 2024 17:21:26 条件 Nasdaq GlobeNewswire
-
29 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
02 7月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
03 6月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
09 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
09 5月 2024 07:00:01 条件 Nasdaq GlobeNewswire
-
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
07 5月 2024 07:05:00 条件 Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
07 5月 2024 07:00:01 条件 Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
28 3月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
25 3月 2024 16:56:42 条件 Nasdaq GlobeNewswire
-
21 3月 2024 10:31:12 条件 Nasdaq GlobeNewswire
-
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 2月 2024 19:01:00 条件 Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
04 1月 2024 16:40:44 条件 Nasdaq GlobeNewswire
-
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 12月 2023 18:00:00 条件 Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
29 11月 2023 16:05:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >